HOPE BANCORP, INC. (HOPE): what the price assumes

In the published model solve dated 2026-Q2, anchored at $13.92, HOPE BANCORP, INC. (HOPE) is priced for 8.6% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/HOPE

Headline

FieldValue
TickerHOPE
CompanyHOPE BANCORP, INC.
Current price$13.92/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed8.6%
Return on equity now2.7%
ROE gap+5.9pp
Price-to-book0.77x

Solve inputs: computed at a 10% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2026).

How unusual the bet is: within-range

ReferenceValue
vs own history+0.47σ
cohort percentile (of 122 peers)2
sustained it ~10 years at this level80%
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.29x3expensive
Earnings1.29x1expensive
Relative0
Growth0.78x2justifies

Families that justify the price: Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.0%); the inversion above states its own rate.

Per-Model Detail (n=6)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)$6.322.20xyesTBVPS $13.85 × 0.46x (ROE (TTM) 5.6% / CoE 9.3%, g=3.6% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption), credit 1.04% allowance/loans → ×0.92, NPL 0.76% → ×0.99)
Relative ValuationRelativenoP/E 10x (static sector reference · 2026-04), scenarios: 8.2x / 10.0x / 11.8x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowth$16.060.87xyesDPS $0.56, g=5.6% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$19.870.70xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$10.821.29xyesBV/sh $17.97, ROE (TTM) 5.6%, ke 9.3%
Two-Stage Excess ReturnAsset$8.051.73xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthnoRev $0.5B, growth 20% (input: historical growth; tapered), Terminal P/S: 2.9x / 3.5x / 4.1x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelativenoEPS $1.00, growth 35% (input: historical EPS growth), PEG=0.40 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAsset$20.110.69xyes√(22.5 × EPS $1.00 × BVPS $17.97) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsnoEPS $1.00 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelativenoEPS $1.00 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$10.811.29xyesEPS $1.00 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Banking Operationsfinancialequity0.5B reported-currencywithheldunresolved standalone equity facts required

No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.

Solvency

FieldValue
Share count CAGR (dilution)1.5%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

The earnings trajectory is the bull case, and it has turned sharply upward. First-quarter 2026 net income of $29.5 million, or $0.23 per diluted share, was up 40% from $21.1 million a year earlier, and the quality of that growth is what matters: net interest income rose 23% to $124 million and pre-provision net revenue, the cleanest measure of core earning power before credit costs, jumped 43% to $46.6 million. A bank whose pre-provision revenue is growing in the low forties is widening the engine that generates profit, not just enjoying a one-time tailwind.

The net interest margin tells a story of disciplined liability management. The margin held at 2.90%, unchanged from the prior quarter, because deposit costs fell faster than asset yields, with the cost of interest-bearing deposits dropping to 3.37%. In a difficult rate environment, holding the margin steady while growing the balance sheet is the harder achievement, and it shows the bank is funding its loan growth with deposits it is repricing lower rather than chasing expensive money.

The growth has a clear external engine: acquisitions that scale the franchise. The Territorial Bancorp deal already contributed to the year-over-year jump in loans and deposits, and the bank announced an accretive purchase of SMBC MANUBANK's commercial banking unit, expected to close in the second half of 2026 and add roughly $2.5 billion of loans and $2.7 billion of deposits, funded without issuing new shares and projected to be meaningfully accretive to 2027 earnings with a roughly two-year tangible book earn-back. The bank's capital is solid, with total capital well above regulatory minimums. The bull case is a recovering regional bank compounding through well-priced, non-dilutive acquisitions while trading below its book value.

Bear Case

The price leans on a recovery and an acquisition narrative, and both have to keep delivering for the stock to work. At today's price the market assumes the bank sustains a return on equity around 8.5%, while its trailing return has recently run far below that, near the low single digits. The Q1 surge is real, but it is one strong quarter measured against a depressed base, and the implied return requires the recovery to continue and the MANUBANK deal to deliver its promised accretion on schedule. Narrative-dependent re-ratings are fragile precisely because they price the plan rather than the demonstrated run rate.

The most fragile assumption sits in the loan book. Hope Bancorp is concentrated in commercial real estate, and its own 10-K flags that because of that concentration, regulators may require it to maintain higher levels of capital than we would otherwise be expected to maintain, which could limit our ability to leverage our capital. Commercial real estate has been under sustained pressure from higher rates and shifting demand for office and retail space, and a regional bank with this exposure carries the risk that credit normalizes upward just as the earnings recovery is being extrapolated. A rising allowance for credit losses would flow straight through the pre-provision growth the bull case celebrates.

The net interest margin, at 2.90%, is also notably below stronger peers, a reminder that this is a thinner-margin franchise than the best-in-class regionals. The margin held steady this quarter because deposit costs fell, but in a different rate path that dynamic can reverse, compressing the spread the bank earns. And the acquisition strategy itself is a double-edged sword: integrating Territorial and then MANUBANK carries execution and credit-mark risk, and a two-year tangible book earn-back means the deal dilutes tangible book value before it adds to it. The bear case is that a sub-book valuation is the market's honest read on a CRE-heavy, thin-margin bank whose earnings recovery and deal accretion are projections, not yet a track record.

Valuation

A bank is valued on the return it earns on its capital, read through price-to-book rather than an earnings multiple, and Hope Bancorp trades at roughly 0.7 times book, a discount to its accounting net worth. That price embeds a sustained return on equity near 8.5%. The reference point is instructive: the bank's trailing return has recently been well below that, in the low single digits, so the price is paying for a recovery toward a more normal return rather than extrapolating the depressed past. A sub-book multiple is the market saying it is not yet convinced the recovery is durable.

The families of method are unusual here, and worth reading carefully. None of them reaches the current price, which for a bank trading below book means the recent earnings power has been too weak to justify even a discounted multiple on a trailing basis. The valuation case therefore rests entirely on forward improvement: the 40% year-over-year jump in net income and the 43% rise in pre-provision revenue are the evidence that the trailing numbers understate the run rate the bank is now achieving. If that recovery holds, a 0.7-times-book multiple is cheap; if it stalls, the discount is deserved.

For a bank, solvency is read through regulatory capital rather than corporate leverage, and Hope Bancorp's capital sits comfortably above the required minimums, giving it room to absorb credit costs and fund acquisitions without raising equity. The MANUBANK purchase is explicitly being funded without new shares, which protects existing holders from dilution. The valuation comes down to a single question the methods cannot answer on trailing data alone: whether the Q1 earnings inflection and the deal-driven scale push the return on equity up toward the 8.5% the price assumes.

Catalysts

The Q1 2026 report, released in late April, was an earnings-recovery story. Net income of $29.5 million, or $0.23 per diluted share, rose 40% from a year earlier, net interest income grew 23% to $124 million, and pre-provision net revenue increased 43% to $46.6 million, with results reflecting both organic growth and the strategic benefits of the Territorial Bancorp acquisition. The net interest margin held at 2.90% as the cost of interest-bearing deposits declined to 3.37%, evidence of effective liability management in a tough rate environment.

The defining forward catalyst is the announced purchase of SMBC MANUBANK's commercial banking unit, expected to close in the second half of 2026, adding roughly $2.5 billion of loans and $2.7 billion of deposits, funded without issuing new shares and projected to be meaningfully accretive to 2027 earnings with a roughly two-year tangible book earn-back. The key things to watch are whether that deal closes on its expected timeline and delivers its accretion, whether the net interest margin holds or improves as deposit costs reprice, and the credit performance of the commercial real estate book, which is the largest single risk to the earnings recovery the price is counting on.

Peer Cohorts (Per Segment, With Filing Citations)

Banking Operations (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release

View the full interactive HOPE report on boothcheck